Author

W. P. Yong

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

P. Tan· 3 shared H. Yang· 2 shared M. C. H. Ng· 2 shared O. An· 2 shared S. Lim· 2 shared A. D. Jeyasekharan· 1 shared A. Larbi· 1 shared A. Shendre· 1 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

P. Tan

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJun 1, 2021

PLK1 inhibition selectively kills ARID1A deficient cells through uncoupling of oxygen consumption from ATP production

U. S. Srinivas, G. K. Ramachandran, J. D. Wardyn…·A. D. Jeyasekharan

This study identifies ARID1A deficiency as a biomarker for PLK1 inhibitor sensitivity by revealing a mitochondrial metabolic vulnerability in these cells.

DOI 10.1101/2021.06.01.446664

humanproteomics

𝕏 PostBluesky

Cancer BiologyCancer ResearchPeer-reviewedFeb 8, 2021

"3G" Trial: An RNA Editing Signature for Guiding Gastric Cancer Chemotherapy

O. An, Y. Song, X. Ke…·Singapore Gastric Cancer Consortium (SGCC)

The paper develops an RNA editing signature (GCRE) to predict chemotherapy response in gastric cancer, achieving 84% accuracy and showing better outcomes in patients with higher editing levels.

DOI 10.1158/0008-5472.can-20-2872

humanbulk RNA-seq

𝕏 PostBluesky

ImmunologybioRxivPreprintOct 23, 2020

Proliferative and quiescent human gastric cancer stem-like cells are associated with differential chemoresistance and patient mortality

K. S. Ang, H. K. Lee, M. Chevrier…·J. Chen

This study identifies two stem-like gastric cancer subpopulations with distinct chemoresistance and survival outcomes using scRNA-seq and organoid models.

DOI 10.1101/2020.10.23.351726

humanscRNA-seq

𝕏 PostBluesky